Literature DB >> 22810131

Neurologic complications of radiation.

Lisa R Rogers1.   

Abstract

PURPOSE OF REVIEW: Radiation administered to treat CNS neoplasms or systemic cancers adjacent to the CNS can result in a variety of acute, subacute, and delayed clinical syndromes of the brain and spinal cord. Less commonly, the brachial or lumbosacral plexus or the cranial nerves are damaged by radiation therapy (RT). Cranial blood vessels can also be affected by brain RT, especially when it is administered during childhood and results in delayed vessel structural changes. These disorders are important because their presentation can mimic tumor recurrence. Knowledge of the classic clinical signs, imaging features, and time interval from RT will assist the practitioner in establishing the diagnosis and recommending treatment when appropriate. RECENT
FINDINGS: The acute and subacute syndromes are temporary. An important subacute syndrome following focal external beam RT in combination with chemotherapy to treat newly diagnosed glioblastoma, termed pseudoprogression, has recently been characterized. In addition, recent clinical experience indicates that the delayed RT-induced CNS syndromes, once considered irreversible, can be treated effectively in some patients.
SUMMARY: Recent and ongoing research is lending new insights into the mechanisms of RT-related CNS injury and will hopefully lead to more effective methods for the prevention and treatment of this undesired, but typically unavoidable, complication of RT.

Entities:  

Mesh:

Year:  2012        PMID: 22810131     DOI: 10.1212/01.CON.0000413662.35174.a8

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  9 in total

1.  Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.

Authors:  Alissa A Thomas; Julio Arevalo-Perez; Thomas Kaley; John Lyo; Kyung K Peck; Weiji Shi; Zhigang Zhang; Robert J Young
Journal:  J Neurooncol       Date:  2015-08-15       Impact factor: 4.130

Review 2.  Imaging findings in radiation therapy complications of the central nervous system.

Authors:  Tomonori Kanda; Yuichi Wakabayashi; Feibi Zeng; Yoshiko Ueno; Keitaro Sofue; Takaki Maeda; Munenobu Nogami; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2018-07-24       Impact factor: 2.374

Review 3.  Cancer-treatment-induced neurotoxicity--focus on newer treatments.

Authors:  Jacqueline B Stone; Lisa M DeAngelis
Journal:  Nat Rev Clin Oncol       Date:  2015-09-22       Impact factor: 66.675

4.  Altered self-perception in adult survivors treated for a CNS tumor in childhood or adolescence: population-based outcomes compared with the general population.

Authors:  Lina Hörnquist; Jenny Rickardsson; Birgitta Lannering; Göran Gustafsson; Krister K Boman
Journal:  Neuro Oncol       Date:  2014-10-20       Impact factor: 12.300

5.  A preclinical murine model for the early detection of radiation-induced brain injury using magnetic resonance imaging and behavioral tests for learning and memory: with applications for the evaluation of possible stem cell imaging agents and therapies.

Authors:  Ethel J Ngen; Lee Wang; Nishant Gandhi; Yoshinori Kato; Michael Armour; Wenlian Zhu; John Wong; Kathleen L Gabrielson; Dmitri Artemov
Journal:  J Neurooncol       Date:  2016-03-28       Impact factor: 4.130

Review 6.  Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.

Authors:  Samantha J Mayo; Maryam Lustberg; Haryana M Dhillon; Zev M Nakamura; Deborah H Allen; Diane Von Ah; Michelle C Janelsins; Alexandre Chan; Karin Olson; Chia Jie Tan; Yi Long Toh; Jeong Oh; Lisa Grech; Yin Ting Cheung; Ishwaria Mohan Subbiah; Duska Petranovic; James D'Olimpio; Margherita Gobbo; Susanne Koeppen; Charles L Loprinzi; Linda Pang; Shivani Shinde; Olanipekun Ntukidem; Katherine B Peters
Journal:  Support Care Cancer       Date:  2020-11-24       Impact factor: 3.603

7.  Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study.

Authors:  Hongqing Zhuang; Hongxia Zhuang; Siyu Shi; Yuxia Wang
Journal:  Onco Targets Ther       Date:  2019-10-11       Impact factor: 4.147

8.  A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis.

Authors:  Hongqing Zhuang; Xiangkun Yuan; Yi Zheng; Xubin Li; Joe Y Chang; Junjie Wang; Xiaoguang Wang; Zhiyong Yuan; Ping Wang
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

9.  Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.

Authors:  Hongqing Zhuang; Xiangkun Yuan; Joe Y Chang; Yongchun Song; Junjie Wang; Zhiyong Yuan; Xiaoguang Wang; Ping Wang
Journal:  Oncotarget       Date:  2016-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.